Lv2
160 积分 2023-02-23 加入
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
5个月前
已完结
Circulating tumor DNA in urothelial cancer as an intermediate disease state between localized and advanced stages: Moving from risk factors to micrometastatic disease in the perioperative setting
5个月前
已关闭
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
5个月前
已完结
结直肠癌KRAS、NRAS和BRAF基因罕见突变类型及其临床意义(附1 513例)
6个月前
已关闭
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
7个月前
已完结
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
7个月前
已完结
ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway
7个月前
已完结
皖公网安备34019202002308
